The impact of vitamin D levels on glycemic control and bone mineral density in postmenopausal women with type 2 diabetes
Tóm tắt
Whether glycemic control contributes to a decreased number of fractures or favorably impacts bone density in patients with type 2 diabetes mellitus (T2DM) has not been well established. Vitamin D (25 (OH) D3) deficiency appears to be related to glycemic control in patients with T2DM. The aim of this study was to determine the relationship between 25 (OH) D3 levels, glycemic control, bone mineral density (BMD), and the development of osteoporotic fractures (OPF) in postmenopausal women with T2DM.
We reviewed the charts of 110 postmenopausal women diagnosed with T2DM. Glycosylated hemoglobin A1c (HbA1c) values over the previous 5 years were recorded and an average was obtained. Based on these values, the patients were divided into three groups: optimal, suboptimal, and poor control. Bone mineral density and 25 (OH) D3 levels were also recorded. In the group of patients with poorly controlled T2DM, 25 (OH) D3 levels were not significantly lower in comparison with the optimal control group 19.29 ± 7.70 vs 17.26 ± 6.93 (p = 0.53). No statistically significant linear relationship between HbA1c and 25 (OH) D3 levels (r
s = −0.17, p = 0.06) was established. The frequency of osteoporosis and osteopenia was not significantly different between groups. The group with optimal glycemic control had an increased number of OPF events (p = 0.04). We do not appreciate a significant relationship between 25 (OH) D3 levels and glucose control or OPF. Therefore, more studies are needed to identify the specific effect of 25 (OH) D3 in T2DM physiopathology.
Tài liệu tham khảo
Sealand R, Razavi C, Adler RA (2013) Diabetes mellitus and osteoporosis. Curr DiabRep 13:411–418
Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237
Abdulameer SA, Sulaiman SAS, Hassali MAA, Subramaniam K, Sahib MN (2012) Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? Patient Prefer Adherence 6:435–448
Melton JL (1995) Perspectives: how many women have osteoporosis now? J Bone Miner Res 10:175–177
Patel S, Hyer S, Tweed K, Kerry S, Allan K, Rodin A, Barron J (2008) Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int 82:87–91
Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, Newman AB (2004) Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: the health, aging, and body composition study. J Bone Miner Res 19:1084–1091
Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Margolis KL (2006) Risk of fracture in women with type 2 diabetes: the women’s health initiative observational study. J Clin Endocrinol Metab 91:3404–3410
Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes a meta-analysis. Osteoporos Int 18:427–444
De Liefde II, Van der Klift M, De Laet CEDH, Van Daele PLA, Hofman A, Pols HAP (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720
Schwartz A (2013) Diabetes mellitus: does it affect bone? Calcif Tissue Int 73:515–519
Hofbauer L, Brueck C, Singh S, Dobnig H (2007) Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22:1317–1328
Farr JN, Drake MT, Amin S, Melton LJ, McCready LK, Khosla S (2014) In Vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 29:787–795
Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, Rubin MR (2012) Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int 23:635–641
Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029
Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247–1257
Eliades M, Pittas AG (2009) Vitamin D and type 2 diabetes. Clin Rev Bone Miner Metab 7:185–198
Song HR, Park CH (2013) Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women. J Endocrinol Invest 36(10):791–796
Kositsawat J, Freeman VL, Gerber BS, Geraci S (2010) Association of A1C levels with vitamin D status in US adults data from the national health and nutrition examination survey. Diabetes Care 33:1236–1238
Gilaberte Y, Aguilera J, Carrascosa JM, Figueroa FL, de Gabriel JR, Nagore E (2011) La vitamina D: evidencias y controversias. Actas Dermosifiliogr 102:572–588
Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Daly RM (2012) Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at 5 years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: ausDiab). J Clin Endocrinol Metab 97:1953–1961
Chiu KC, Chu A, Go VLW, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79:820–825
Kostoglou-Athanassiou I, Athanassiou P, Gkountouvas A, Kaldrymides P (2013) Vitamin D and glycemic control in diabetes mellitus type 2. Ther Adv Endocrinol Metab 4:122–128
Holick M (2008) Diabetes and the vitamin D connection. Curr Diab Rep 8:393–398
Bellan M, Guzzaloni G, Rinaldi M, Merlotti E, Ferrari C, Tagliaferri A, Marzullo P (2014) Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. Cardiovasc Diabetol 13:57
Mathew CS, Dominic M, Isaac R, Jacob JJ (2012) Prevalence of depression in consecutive patients with type 2 diabetes mellitus of 5-year duration and its impact on glycemic control. Indian J Endocrinol Metab 16:764–768
Holick M (2007) Vitamin D deficiency. N Engl J Med 357:266–281
Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85:752–758
Tothill P, Hannan WJ (2007) Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry. Osteoporos Int 18(11):1515–1523
Hans D, Duboeuf F, Schott AM, Horn S, Avioli LV, Drezner MK et al (1997) Effects of a new positioner on the precision of hip bone mineral density measurements. J Bone Miner Res 12(8):1289–1294
Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Petak SM (2010) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16:1–37
Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Chrousos GP (2012) Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 11:85
Osei K (2010) 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab 95:4220–4222
Mitri J, Muraru MD, Pittas AG (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65:1005–1015
Chiu KC, Chu A, Go VLW, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79:820–825
Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247–1257
Wongwiwatthananukit S, Sansanayudh N, Phetkrajaysang N, Krittiyanunt S (2013) Effects of vitamin D(2) supplementation on insulin sensitivity and metabolic parameters in metabolic syndrome patients. J Endocrinol Invest 36(8):558–563
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693
Landrier JF, Marcotorchino J, Tourniaire F (2012) Lipophilic micronutrients and adipose tissue biology. Nutrients 4:1622–1649
Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, Draz HM et al (2013) Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with type 2 diabetes mellitus: a body mass index-independent role of adiponectin? J Endocrinol Invest 36(1):1–6
Ivers RQ, Cumming RG, Mitchell P, Peduto AJ (2001) Diabetes and risk of fracture the blue mountains eye study. Diabetes Care 24:1198–1203
De Liefde II, Van der Klift M, De Laet CEDH, Van Daele PLA, Hofman A, Pols HAP (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720
Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Newman AB (2005) Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165:1612–1617
Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Bauer DC (2012) Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care 35:1525–1531
Hamann C, Kirschner S, Günther KP, Hofbauer LC (2012) Bone, sweet bone—osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8:297–305
Zhukouskaya VV, Ellen-Vainicher C, Gaudio A, Privitera F, Cairoli E, Ulivieri FM, Palmieri S, Morelli V, Grancini V, Orsi E, Masserini B, Spada AM, Fiore CE, Chiodini I (2015) The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients. Osteoporos Int 3:1–8
Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Kovacs CS (2012) The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33:456–492
He R, Shen J, Liu F, Zeng H, Li L, Yu H, Lu H, Lu F, Wu Q, Jia W (2014) Vitamin D deficiency increases the risk of retinopathy in Chinese patients with type 2 diabetes. Diabet Med 31(12):1657–1664